
|Videos|April 21, 2022
Novel Agents Under Investigation for Multiple Myeloma
Oncologists highlight novel agents currently being investigated for the treatment of relapsed/refractory multiple myeloma.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Afami-cel in Metastatic Synovial Sarcoma
2
How Are Key Lymphoma Data From ASCO and EHA 2026 Shaping Treatment?
3
Current Treatment Landscape of HER2-Positive Metastatic Breast Cancer and Phase 3 Trial Overview
4
Binimetinib Tablets Receive Tentative FDA Approval in Melanoma/NSCLC
5



















































































